News

The Star13d
First third-gen artificial heart implant successfully performed in Vietnam
According to Dr. Dang Viet Duc, Deputy Director of the Cardiology Institute at 108 Military Central Hospital, the HeartMate 3 LVAD is among the most advanced cardiovascular technologies currently ...
Morningstar1mon
Cadrenal Therapeutics Announces Collaboration Agreement with Abbott in Support of Pivotal Study of Tecarfarin in Patients with HeartMate 3™ LVAD
Strengthens the Potential for Improved Patient Outcomes through Improvements in the Quality of Anticoagulation, Enhancing Hemocompatibility in HeartMate 3™ LVAD patients Cadrenal Therapeutics ...
Hosted on MSN1mon
Cadrenal and Abbott sign agreement for LVAD trial of tecarfarin
The company will receive Abbott’s insights from recent HeartMate 3 trials, including its support in designing the study, site recognition, trial awareness, and “expertise” on the HeartMate 3 ...